Portuguese Registry With Meril Myval THV Series - MyPORTuVal Registry

NCT ID: NCT06818435

Last Updated: 2026-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-13

Study Completion Date

2028-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective, single-arm, multi-centre registry to evaluate the safety and performance of Myval THV series using Transcatheter Aortic Valve Implantation (TAVI) procedure in patients with symptomatic severe native aortic valve stenosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Stenosis TAVI(Transcatheter Aortic Valve Implantation)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Myval THV series

Transcatheter Aortic Valve Implantation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient over the age of 18 years with symptomatic aortic stenosis (severe AS), intended to perform TAVI procedure using Myval THV series as assessed by Heart Team.
2. Patient has provided written informed consent as approved by the Ethics Committee (EC)
3. Patient is willing to undergo all registry procedures and follow-up requirements

Exclusion Criteria

1. Patients with hyper sensitivity or allergy to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum or any contrast media.
2. Ongoing infective endocarditis or any similar infection.
3. Pregnant or lactating females.
4. Liver failure (Child-Pugh Class B or C)
5. Patient is currently participating in another clinical investigation where the primary endpoint has not been achieved.
6. Any condition, which in the investigator opinion, would preclude safe participation of the patient in the Registry.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Meril Life Sciences Pvt. Ltd.

INDUSTRY

Sponsor Role collaborator

Portuguese Association of Interventional Cardiology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rui Campante Teles, Prof. Dr.

Role: STUDY_CHAIR

Unidade Local de Saúde de Lisboa Ocidental, E.P.E. - Hospital de Santa Cruz

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Unidade Local de Saúde do Lisboa Ocidental E.P.E. - Hospital Santa Cruz

Carnaxide, , Portugal

Site Status RECRUITING

Unidade Local de Saúde de Coimbra

Coimbra, , Portugal

Site Status RECRUITING

Unidade Local de Saúde Alentejo Central E.P.E. - Hospital Espírito Santo

Evora, , Portugal

Site Status RECRUITING

Unidade Local de Saúde de São José E.P.E. - Hospital Santa Marta

Lisbon, , Portugal

Site Status NOT_YET_RECRUITING

Unidade Local de Saúde de Santa Maria, E.P.E. - Hospital de Santa Maria

Lisbon, , Portugal

Site Status RECRUITING

Unidade Local de São João E.P.E.

Porto, , Portugal

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ana Domingues

Role: CONTACT

+351217970685

Joana D Silva, MD

Role: CONTACT

+351217970685

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sílvio Leal, MD

Role: primary

+351210431000

Joana D Silva, Prof. Dr.

Role: primary

Lino Patrício, Prof. Dr.

Role: primary

+351 266 740 100

Duarte Cacela, MD

Role: primary

+351 21 359 4000

Pedro C Ferreira, MD

Role: primary

Domingos Magalhães

Role: primary

+351 225 512 100

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MyPTVal-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Valvular Heart Disease Registry
NCT03488732 RECRUITING
SwissTAVI Registry
NCT01368250 RECRUITING
VARC-TAVI VALVE IMPLANTATION)
NCT06177392 NOT_YET_RECRUITING NA
TAVR for Aortic Valve Disease
NCT05439863 RECRUITING